These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2726755)

  • 21. Activation of human monocyte--derived macrophages with lipopolysaccharide decreases human immunodeficiency virus replication in vitro at the level of gene expression.
    Bernstein MS; Tong-Starksen SE; Locksley RM
    J Clin Invest; 1991 Aug; 88(2):540-5. PubMed ID: 1907615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An Epstein-Barr virus immediate-early gene product trans-activates gene expression from the human immunodeficiency virus long terminal repeat.
    Kenney S; Kamine J; Markovitz D; Fenrick R; Pagano J
    Proc Natl Acad Sci U S A; 1988 Mar; 85(5):1652-6. PubMed ID: 2830625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of human immunodeficiency virus type-1 by retroviral vectors expressing antisense-TAR.
    Chuah MK; VandenDriessche T; Chang HK; Ensoli B; Morgan RA
    Hum Gene Ther; 1994 Dec; 5(12):1467-75. PubMed ID: 7711139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transactivation of human immunodeficiency virus by herpesviruses.
    Rando RF; Pellett PE; Luciw PA; Bohan CA; Srinivasan A
    Oncogene; 1987 Mar; 1(1):13-8. PubMed ID: 2830574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trans-activation of the human immunodeficiency virus long terminal repeat by the hepatitis B virus X protein.
    Seto E; Yen TS; Peterlin BM; Ou JH
    Proc Natl Acad Sci U S A; 1988 Nov; 85(21):8286-90. PubMed ID: 3186723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential expression in human and mouse cells of human immunodeficiency virus pseudotyped by murine retroviruses.
    Chesebro B; Wehrly K; Maury W
    J Virol; 1990 Sep; 64(9):4553-7. PubMed ID: 2166831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapidly and slowly replicating human immunodeficiency virus type 1 isolates can be distinguished according to target-cell tropism in T-cell and monocyte cell lines.
    Schwartz S; Felber BK; Fenyö EM; Pavlakis GN
    Proc Natl Acad Sci U S A; 1989 Sep; 86(18):7200-3. PubMed ID: 2789383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Silencing of human immunodeficiency virus long terminal repeat expression by an adenovirus E1a mutant.
    Ventura AM; Arens MQ; Srinivasan A; Chinnadurai G
    Proc Natl Acad Sci U S A; 1990 Feb; 87(4):1310-4. PubMed ID: 2137611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Structure and biological properties of human immunodeficiency viruses (HIV)].
    Hartmann H; Hunsmann G
    Internist (Berl); 1988 Feb; 29(2):67-72. PubMed ID: 3286565
    [No Abstract]   [Full Text] [Related]  

  • 30. Mutational analysis of the human immunodeficiency virus vpr open reading frame.
    Ogawa K; Shibata R; Kiyomasu T; Higuchi I; Kishida Y; Ishimoto A; Adachi A
    J Virol; 1989 Sep; 63(9):4110-4. PubMed ID: 2474678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV-1 Vpr-chloramphenicol acetyltransferase fusion proteins: sequence requirement for virion incorporation and analysis of antiviral effect.
    Yao XJ; Kobinger G; Dandache S; Rougeau N; Cohen E
    Gene Ther; 1999 Sep; 6(9):1590-9. PubMed ID: 10490769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calmodulin antagonists inhibit human immunodeficiency virus-induced cell fusion but not virus replication.
    Srinivas RV; Bernstein H; Oliver C; Compans RW
    AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1489-96. PubMed ID: 7888203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electrostatic interactions modulate the RNA-binding and transactivation specificities of the human immunodeficiency virus and simian immunodeficiency virus Tat proteins.
    Tao J; Frankel AD
    Proc Natl Acad Sci U S A; 1993 Feb; 90(4):1571-5. PubMed ID: 8434019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human immunodeficiency virus type 1 vpr protein transactivation function: mechanism and identification of domains involved.
    Forget J; Yao XJ; Mercier J; Cohen EA
    J Mol Biol; 1998 Dec; 284(4):915-23. PubMed ID: 9837715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The human immunodeficiency virus type 1 (HIV-1) vif protein is located in the cytoplasm of infected cells and its effect on viral replication is equivalent in HIV-2.
    Michaels FH; Hattori N; Gallo RC; Franchini G
    AIDS Res Hum Retroviruses; 1993 Oct; 9(10):1025-30. PubMed ID: 8280477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emergence of large plaque-producing clones of human immunodeficiency virus (HIV) in vitro.
    Masuda T; Kannagi M; Nakamura M; Ohtani K; Hinuma Y; Harada S
    J Med Virol; 1989 Feb; 27(2):170-7. PubMed ID: 2921604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reciprocal modulation of transcriptional activities between HIV-1 Tat and MHC class II transactivator CIITA.
    Okamoto H; Asamitsu K; Nishimura H; Kamatani N; Okamoto T
    Biochem Biophys Res Commun; 2000 Dec; 279(2):494-9. PubMed ID: 11118314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic modification of an entomopoxvirus: deletion of the spheroidin gene does not affect virus replication in vitro.
    Palmer CP; Miller DP; Marlow SA; Wilson LE; Lawrie AM; King LA
    J Gen Virol; 1995 Jan; 76 ( Pt 1)():15-23. PubMed ID: 7844525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product.
    Kao SY; Calman AF; Luciw PA; Peterlin BM
    Nature; 1987 Dec 3-9; 330(6147):489-93. PubMed ID: 2825027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of human immunodeficiency virus-1 in human colonic cells.
    Kagnoff MF; Omary MB; de Grandpre LY; Roebuck KA; Richman DD; Brenner DA
    Immunol Res; 1991; 10(3-4):452-5. PubMed ID: 1955772
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.